Title:
化合物及びその使用
Document Type and Number:
Japanese Patent JP2010514682
Kind Code:
A
Abstract:
This invention relates to novel compounds having the structural Formula (I) below: and their pharmaceutically acceptable salts, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of at least one symptom or condition associated with schizophrenia and other psychotic disorders, dementia and other cognitive disorders, anxiety disorders, mood disorders, sleep disorders, disorders usually first diagnosed in infancy, childhood, or adolescence, and neurodegenerative disorders.
Inventors:
Peter Bernstein
James Bee Campbell
James Bee Campbell
Application Number:
JP2009543160A
Publication Date:
May 06, 2010
Filing Date:
December 19, 2007
Export Citation:
Assignee:
ASTRAZENECA AKTIEBOLAG
International Classes:
C07D281/16; A61K31/554; A61K45/00; A61P1/00; A61P25/00; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P43/00
Domestic Patent References:
| JPS638378A | 1988-01-14 | |||
| JPH0565257A | 1993-03-19 |
Foreign References:
| WO2005002586A1 | 2005-01-13 | |||
| US20060063754A1 | 2006-03-23 |
Other References:
JPN6013005284; Ｊ． Ｍｅｄ． Ｃｈｅｍ． Ｖｏｌ．４４, 2001, Ｐ．３７２-３８９
Attorney, Agent or Firm:
Junji Yuda
Shoji Miwa
Noriyuki Takebayashi
Chika Takagi
Shoji Miwa
Noriyuki Takebayashi
Chika Takagi